| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $7.22 | $6.55 | $6.45 | $5.89 | $5.12 | $3.05 | $1.09 | $1.00 |
| EPS (Diluted) | $7.11 | $6.44 | $6.34 | $5.77 | $5.03 | $3.00 | $1.07 | $0.98 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.8B | $13.6B | $12.4B | $12.4B | $9.4B | $9.2B | $8.6B | $7.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | $1.4B |
| Total Liabilities | $13.0B | $11.9B | $10.9B | $11.1B | $8.2B | $8.1B | $7.6B | $6.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.9B | $1.6B | $1.4B | $1.3B | $1.2B | $1.1B | $1.0B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Investing Cash Flow | $0.0B | $-0.1B | $-0.7B | $-1.5B | $0.4B | $-0.9B | $0.1B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.1B |
| Financing Cash Flow | $0.5B | $1.0B | $-0.3B | $2.4B | $-0.2B | $0.5B | $0.2B | $-0.2B |